ALECAlector, Inc.

ALEC Stock Price, Valuation & Chart | Alector, Inc.

Compare

$2.720+0.32 (+13.33%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ALEC intrinsic value ALEC calculated fair value vs price

Overview Financials Dividends Ratios

ALEC Historical price chart

ALEC Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization301.99M

PE Ratio-2.47

EPS-1.1

Trading Volume1.66M

Today's High/Low2.76/2.4

Dividend Yield0.00

52 Week High/Low3.4/1.09

Shares Outstanding111.03M

ALEC Financial Statement

ALEC Analyst ratings

ALEC Analysis & performance metrics

ALEC Company profile

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized…

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I…

ALEC Management team

Name

Position

Saraswati Kenkare-Mitra Ph.D.

President and Head of Research & Development

Danielle Pasqualone J.D., Ph.D.

General Counsel

Kristina Cutter M.P.H.

Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer

Katie HoganCTO

Senior Director of Corporate Communication & Investor Relations

Giacomo Salvadore M.D.

Chief Medical Officer

Clare Hunt M.B.A.

Chief People Officer

Virginia DeJesus-Rueff M.B.A.

Chief of Staff & Head of Strategy

Arnon Rosenthal Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Name

Position

Saraswati Kenkare-Mitra Ph.D.

President and Head of Research & Development

Danielle Pasqualone J.D., Ph.D.

General Counsel

Kristina Cutter M.P.H.

Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer

Katie HoganCTO

Senior Director of Corporate Communication & Investor Relations

Giacomo Salvadore M.D.

Chief Medical Officer

Clare Hunt M.B.A.

Chief People Officer

Virginia DeJesus-Rueff M.B.A.

Chief of Staff & Head of Strategy

Arnon Rosenthal Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Management Team

Saraswati Kenkare-Mitra Ph.D.

President and Head of Research & Development

Danielle Pasqualone J.D., Ph.D.

General Counsel

Kristina Cutter M.P.H.

Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer

Katie HoganCTO

Senior Director of Corporate Communication & Investor Relations

Giacomo Salvadore M.D.

Chief Medical Officer

Clare Hunt M.B.A.

Chief People Officer

Virginia DeJesus-Rueff M.B.A.

Chief of Staff & Head of Strategy

Arnon Rosenthal Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Management

Saraswati Kenkare-Mitra Ph.D.

President and Head of Research & Development

Danielle Pasqualone J.D., Ph.D.

General Counsel

Kristina Cutter M.P.H.

Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer

Katie HoganCTO

Senior Director of Corporate Communication & Investor Relations

Giacomo Salvadore M.D.

Chief Medical Officer

Clare Hunt M.B.A.

Chief People Officer

Virginia DeJesus-Rueff M.B.A.

Chief of Staff & Head of Strategy

Arnon Rosenthal Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Total 8 executives

ALEC Frequently asked questions

What is Alector, Inc. (ALEC) Stock Price?

Current stock price of Alector, Inc. (ALEC) stock is $2.720. The stock price is +13.33% higher in the session. The intraday range can be seen from this page. Volume of Alector, Inc. (ALEC) stock is 1.66M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Alector, Inc. (ALEC) stock price going up or down today?

The stock price of Alector, Inc. (ALEC) can change with earnings, company news, and overall market sentiment. Alector, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Alector, Inc. stock expensive at its current price?

Whether Alector, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ALEC on this page is -2.47. EPS on this page is -1.10. Compare those figures with peers and growth expectations before deciding if the current Alector, Inc. price is justified.

How has the stock price of Alector, Inc. (ALEC) performed historically?

Historical performance for Alector, Inc. (ALEC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ALEC reacted to past earnings and market events.

Should I buy Alector, Inc. (ALEC) stock, at this price?

Buying Alector, Inc. (ALEC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.